|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Nutrify Today hosts Sumflex event for nutraceutical industry in Mumbai
|
|
Friday, 12 June, 2026, 08 : 00 AM [IST]
|
|
Our Bureau, Mumbai
|
The fifth edition of Nutrify Today’s C-Suite Sumflex concluded at Trident Oberoi in Mumbai, cementing its position as the nutraceutical industry’s most influential leadership gathering. Over two days more than 150 C-suite leaders from global pharma, regulation, venture capital, and ingredient science and technology converged on a single question: How can India and the world move responsible nutrition from promise to proven, investible scale?
Participation spanned global pharma majors including Novo Nordisk, MSD, Mankind Pharma, Torrent Pharma, Dr Reddy’s–Nestlé Health Science, Reckitt and Sanofi; regulatory and policy voices from FSSAI, the FDA Maharashtra, the Indian Pharmaceutical Alliance and OPPI; investors such as Fire Side Ventures and Peak Bridge VC; and ingredient innovators including Arjuna Natural, Greenspace Herbs and Zeon Lifesciences. Leaders from the United States, the Middle East and Uzbekistan gave the proceedings a distinctly cross-border texture.
The agenda matched the calibre of the room. High-impact sessions ranged from a GLP-1 fireside on obesity and metabolic control to a hard-hitting panel on counterfeit nutrition, ‘Fake Nutrition: Anatomy of a Crime’, to dedicated tracks on women-led wellness brands and AI-powered commercialisation, with the latter showcased through live demonstrations of Nutrify Today’s own generative AI stack.
Amit Srivastava, founder & chief catalyst, Nutrify Today, said, “When we started, the Indian nutraceutical industry didn’t have a room of its own. Five editions later, it has a global one. Sumflex was never meant to be just an event; it was meant to be the table where science, capital, regulation, and the market sit together and decide. If Davos is where the world’s economy meets, this is fast becoming where the world’s nutrition economy chooses to meet."
Vikrant Shrotriya, managing director, Novo Nordisk India, said, "GLP-1 therapies are reshaping the global conversation around obesity, metabolic health, and chronic disease management. As healthcare evolves, nutrition is becoming an essential partner in improving patient outcomes, supporting adherence, and enabling long-term health transformation. I am pleased to see NutrifyToday C-Suite Sumflex bringing together leaders from pharma, nutrition science, industry, and policy to address these critical intersections and advance a more integrated approach to preventive and metabolic healthcare."
|
|
|
|
|
|
|
|
|
|